Taste Masking Services Market, 2022-2035: Distribution by Type of Formulation ((Solids and Liquids), Type of Techniques (Coating, Microencapsulation, Organoleptic Method, Hot Melt Extrusion and Inclusion Complexation), Scale of Operation (Preclinical / Clinical and Commercial) and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts
The taste masking service market is expected to reach USD 221 million by 2022 anticipated to grow at a CAGR of 6% during the forecast period 2023-2035
The oral solid dosage (OSD) market is expected to surpass USD 900 billion by 2027, representing the largest segment in the pharmaceutical industry. However, a significant concern within this sector revolves around the unpleasant taste and odor of active pharmaceutical ingredients (APIs) used in orally administered dosage forms. This issue adversely affects patient compliance, particularly among pediatric and geriatric populations. Approximately 30% to 40% of pediatric patients and 26% of the elderly face challenges in swallowing tablets or capsules due to taste or texture issues with medications.
Addressing the bitter taste of drugs presents a substantial challenge due to the complexity of taste receptors on the tongue. Pharmaceutical entities are employing various conventional and innovative techniques, such as sweeteners, coating, microencapsulation, and hot-melt extrusion, to mask the unpleasant taste. Research indicates that implementing taste-masking technologies in oral drugs can significantly improve patient compliance from 53% to 90%.
Pharmaceutical companies are investing heavily in developing appealing and palatable drug formulations while exploring different taste masking agents and assessment procedures tailored for children and elderly patients. However, this process faces challenges, including taste variation among APIs, formulating placebo samples for taste testing, meeting regulatory guidelines, high research expenses, and managing product life cycles. Consequently, many companies are outsourcing taste masking and assessment operations to third-party service providers with expertise in this domain.
Presently, around 50 taste masking service providers offer services aligned with regulatory guidelines to aid in the development and commercialization of taste-masked formulations. Regulatory agencies like the US FDA and the European Medicines Agency have simplified the assessment of taste-masking strategies for drugs. Additionally, there has been an increase in strategic partnerships among industry players to expand taste masking capabilities, ensuring the success of drug formulations. Stakeholders are actively pursuing patient-centric dosage forms suitable for various age groups and exploring novel excipients.
Considering the ongoing efforts to improve the palatability of oral drug formulations, enhance drug adherence, and ensure patient compliance, the taste masking services market is expected to grow steadily in the forecast period.
Report Coverage
The oral solid dosage (OSD) market is expected to surpass USD 900 billion by 2027, representing the largest segment in the pharmaceutical industry. However, a significant concern within this sector revolves around the unpleasant taste and odor of active pharmaceutical ingredients (APIs) used in orally administered dosage forms. This issue adversely affects patient compliance, particularly among pediatric and geriatric populations. Approximately 30% to 40% of pediatric patients and 26% of the elderly face challenges in swallowing tablets or capsules due to taste or texture issues with medications.
Addressing the bitter taste of drugs presents a substantial challenge due to the complexity of taste receptors on the tongue. Pharmaceutical entities are employing various conventional and innovative techniques, such as sweeteners, coating, microencapsulation, and hot-melt extrusion, to mask the unpleasant taste. Research indicates that implementing taste-masking technologies in oral drugs can significantly improve patient compliance from 53% to 90%.
Pharmaceutical companies are investing heavily in developing appealing and palatable drug formulations while exploring different taste masking agents and assessment procedures tailored for children and elderly patients. However, this process faces challenges, including taste variation among APIs, formulating placebo samples for taste testing, meeting regulatory guidelines, high research expenses, and managing product life cycles. Consequently, many companies are outsourcing taste masking and assessment operations to third-party service providers with expertise in this domain.
Presently, around 50 taste masking service providers offer services aligned with regulatory guidelines to aid in the development and commercialization of taste-masked formulations. Regulatory agencies like the US FDA and the European Medicines Agency have simplified the assessment of taste-masking strategies for drugs. Additionally, there has been an increase in strategic partnerships among industry players to expand taste masking capabilities, ensuring the success of drug formulations. Stakeholders are actively pursuing patient-centric dosage forms suitable for various age groups and exploring novel excipients.
Considering the ongoing efforts to improve the palatability of oral drug formulations, enhance drug adherence, and ensure patient compliance, the taste masking services market is expected to grow steadily in the forecast period.
Report Coverage
- The report comprehensively examines the taste masking services market, focusing on factors like formulation types, techniques used, operational scale, and key geographical regions. It evaluates drivers, restraints, opportunities, and challenges impacting market growth, while also considering advantages, obstacles, and the competitive landscape for market leaders.
- Forecasting revenue across major regions, the report assesses taste masking service providers, encompassing their service types (masking and assessment), operational scale (preclinical/clinical, commercial), manufacturing scalability, formulation types catered to, end-user industries, employed taste masking techniques, targeted healthcare segments, and regional capabilities.
- Moreover, it delves into taste masking and assessment technology providers, analyzing their offered services, utilized techniques, supported formulation types, target industries, patent information, and availability for partnerships and licensing. Detailed profiles of major players in taste masking services and technology platform providers are included, offering company overviews, service/technology portfolios, and future perspectives.
- A comprehensive competitive analysis among taste masking service providers globally considers strengths, service portfolios, operational scales, formulation types, techniques used, healthcare focuses, and regional capabilities. It also discusses various partnership models adopted within the field, including asset acquisition, manufacturing agreements, research collaborations, and technology licensing agreements, highlighting collaborating entities' specifics.
- The report examines patents filed/granted for taste masking and assessment since 2017, covering types, publication years, geographical locations, key players, characteristics, focus areas, and valuation analysis. Additionally, it presents a case study on pharmaceutical excipients specialized in taste masking, exploring establishment details, excipient properties, and formulated types.
- AbbVie
- Catalent
- Fertin Pharma
- Lonza
- NextPharma
- Patheon
- Quotient Sciences
- Senopsys
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Bitterness of Oral Drugs and Need for Taste Masking
3.3. Physiology of Taste Buds
3.4. Concept of Taste Masking
3.4.1. Taste Masking Techniques
3.4.1.1. Traditional Methods for Taste Masking
3.4.1.2. Modern Methods for Taste Masking
3.4.2. Selection of Taste Masking Approaches
3.4.3. Taste Masking Excipients
3.5. Introduction to Taste Assessment
3.5.1. Taste Assessment Techniques
3.5.1.1. In vivo Approaches of Taste Assessment
3.5.1.2. In vitro Approaches of Taste Assessment
3.6. Current Scenario and Future Perspective
4. TASTE MASKING AND TASTE ASSESSMENT SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Taste Masking and Taste Assessment Service Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.3. Taste Masking and Taste Assessment Services: Overall Market Landscape
4.3.1. Analysis by Service(s) Offered
4.3.2. Analysis by Scale of Operation
4.3.3. Analysis by Other Service(s) Offered
4.3.4. Analysis by Type of Formulation
4.3.5. Analysis by End Users
4.3.6. Analysis by Techniques Used for Taste Masking
4.3.7. Analysis by Branch of Healthcare
4.3.8. Analysis by Regional Capability
5. TASTE MASKING AND TASTE ASSESSMENT TECHNOLOGY PROVIDERS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Taste Masking and Taste Assessment Technologies: Overall Market Landscape
5.2.1. Analysis by Service(s) Offered
5.2.2. Analysis by Techniques Used
5.2.3. Analysis by Type of Formulation
5.2.4. Analysis by End users
5.3. Taste Masking and Taste Assessment Technology Providers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Analysis by Year of Establishment and Location of Headquarters
5.3.5. Analysis by Company Size and Location of Headquarters
5.3.6. Leading Players: Analysis by Number of Technologies
6. TASTE MASKING AND TASTE ASSESSMENT SERVICE PROVIDERS: COMPANY PROFILES
6.1. Chapter Overview
6.2. AbbVie
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Taste Masking and Taste Assessment Service Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. Catalent
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Service Portfolio
6.3.4. Technology Portfolio
6.3.5. Recent Developments and Future Outlook
6.4. Fertin Pharma
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Technology Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. Lonza
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Service Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. NextPharma
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Patheon
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Service Portfolio
6.7.4. Recent Developments and Future Outlook
6.8. Quotient Sciences
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Senopsys
6.9.1 Company Overview
6.9.2. Service Portfolio
6.9.3. Technology Portfolio
6.9.4. Recent Developments and Future Outlook
7. TASTE MASKING AND TASTE ASSESSMENT TECHNOLOGY PROVIDERS: COMPANY PROFILES
7.1. Chapter Overview
7.2. Adare Pharma Solutions
7.2.1. Company Overview
7.2.2. Technology Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Colorcon
7.3.1. Company Overview
7.3.2. Technology Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Lupin
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Technology Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. Mayne Pharma
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Technology Portfolio
7.5.4. Recent Developments and Future Outlook
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions / Key Parameters
8.3. Methodology
8.4. Company Competitiveness Analysis: Taste Masking and Taste Assessment Service Providers Based in North America
8.5. Company Competitiveness Analysis: Taste Masking and Taste Assessment Service Providers Based in Europe
8.6. Company Competitiveness Analysis: Taste Masking and Taste Assessment Service Providers Based in Asia Pacific
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Taste Masking and Taste Assessment: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Partner
9.3.5. Analysis by Type of Partner and Year of Partnership
9.3.6. Analysis by Type of Service(s) Offered
9.3.7. Analysis by Scale of Operation
9.3.8. Analysis by Type of Formulation
9.3.9. Regional Analysis
9.3.10. Intercontinental and Intracontinental Agreements
9.3.11. Most Active Players based on Number of Partnerships
10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.2.1. Analysis by Type of Patent
10.2.2. Analysis by Patent Publication Year
10.2.3. Analysis by Type of Patent and Publication Year
10.2.4. Analysis by Type of Organization
10.2.5. Analysis by Geographical Distribution
10.2.6. Analysis by CPC Symbols
10.2.7. Leading Non-Academic Players based on Number of Patents
10.2.8. Leading Academic Players based on Number of Patents
10.3. Patent Benchmarking Analysis
10.2.7. Analysis by Patent Characteristics
10.4. Patent Valuation Analysis
10.5. Leading Patents based on Number of Citations
11. CASE STUDY: EXCIPIENTS USED IN PHARMACEUTICAL TASTE MASKING
11.1. Chapter Overview
11.2. Types of Pharmaceutical Excipients
11.3. Pharmaceutical Taste Masking Excipients: Overall Market Landscape
11.3.1. Analysis by Functional Properties
11.3.2. Analysis by Type of Formulation
11.4. Pharmaceutical Taste Masking Excipient Providers: Market Landscape
11.4.1. Analysis by Year of Establishment
11.4.2. Analysis by Company Size
11.4.2. Analysis by Location of Headquarters
11.4.2. Leading Players: Analysis by Number of Excipients
12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3 Global Pharmaceutical Taste Masking Market, 2022-2035
12.3.1. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Type of Formulation
12.3.1.1. Pharmaceutical Taste Masking Market for Solids, 2022-2035
12.3.1.2. Pharmaceutical Taste Masking Market for Solids, 2022-2035
12.3.2. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Type of Technique
12.3.2.1. Pharmaceutical Taste Masking Market for Coating Technique, 2022-2035
12.3.2.2. Pharmaceutical Taste Masking Market for Microencapsulation Technique, 2022-2035
12.3.2.3. Pharmaceutical Taste Masking Market for Organoleptic Method, 2022-2035
12.3.2.4. Pharmaceutical Taste Masking Market for Hot Melt Extrusion Technique, 2022-2035
12.3.2.5. Pharmaceutical Taste Masking Market for Inclusion Complexation Technique, 2022-2035
12.3.3. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Scale of Operation
12.3.3.1. Pharmaceutical Taste Masking Market for Preclinical / Clinical Scale, 2022-2035
12.3.3.2. Pharmaceutical Taste Masking Market for Commercial Scale, 2022-2035
12.3.4. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Key Geographical Regions
12.3.4.1. Pharmaceutical Taste Masking Market in North America, 2022-2035
12.3.4.2. Pharmaceutical Taste Masking Market in Europe, 2022-2035
12.3.4.3. Pharmaceutical Taste Masking Market in Asia Pacific and Rest of the World, 2022-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Glatt Pharmaceutical Services
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Phillipe Tschopp (Head of Business Development)
14.3 Senopsys
14.3.1. Company Snapshot
14.3.2. Interview Transcript: David Tisi (Director of Technical Operations)
14.4. Adare Pharma Solutions
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Brandon Keener (Business Development Associate)
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Bitterness of Oral Drugs and Need for Taste Masking
3.3. Physiology of Taste Buds
3.4. Concept of Taste Masking
3.4.1. Taste Masking Techniques
3.4.1.1. Traditional Methods for Taste Masking
3.4.1.2. Modern Methods for Taste Masking
3.4.2. Selection of Taste Masking Approaches
3.4.3. Taste Masking Excipients
3.5. Introduction to Taste Assessment
3.5.1. Taste Assessment Techniques
3.5.1.1. In vivo Approaches of Taste Assessment
3.5.1.2. In vitro Approaches of Taste Assessment
3.6. Current Scenario and Future Perspective
4. TASTE MASKING AND TASTE ASSESSMENT SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Taste Masking and Taste Assessment Service Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.3. Taste Masking and Taste Assessment Services: Overall Market Landscape
4.3.1. Analysis by Service(s) Offered
4.3.2. Analysis by Scale of Operation
4.3.3. Analysis by Other Service(s) Offered
4.3.4. Analysis by Type of Formulation
4.3.5. Analysis by End Users
4.3.6. Analysis by Techniques Used for Taste Masking
4.3.7. Analysis by Branch of Healthcare
4.3.8. Analysis by Regional Capability
5. TASTE MASKING AND TASTE ASSESSMENT TECHNOLOGY PROVIDERS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Taste Masking and Taste Assessment Technologies: Overall Market Landscape
5.2.1. Analysis by Service(s) Offered
5.2.2. Analysis by Techniques Used
5.2.3. Analysis by Type of Formulation
5.2.4. Analysis by End users
5.3. Taste Masking and Taste Assessment Technology Providers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Analysis by Year of Establishment and Location of Headquarters
5.3.5. Analysis by Company Size and Location of Headquarters
5.3.6. Leading Players: Analysis by Number of Technologies
6. TASTE MASKING AND TASTE ASSESSMENT SERVICE PROVIDERS: COMPANY PROFILES
6.1. Chapter Overview
6.2. AbbVie
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Taste Masking and Taste Assessment Service Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. Catalent
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Service Portfolio
6.3.4. Technology Portfolio
6.3.5. Recent Developments and Future Outlook
6.4. Fertin Pharma
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Technology Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. Lonza
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Service Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. NextPharma
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Patheon
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Service Portfolio
6.7.4. Recent Developments and Future Outlook
6.8. Quotient Sciences
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Senopsys
6.9.1 Company Overview
6.9.2. Service Portfolio
6.9.3. Technology Portfolio
6.9.4. Recent Developments and Future Outlook
7. TASTE MASKING AND TASTE ASSESSMENT TECHNOLOGY PROVIDERS: COMPANY PROFILES
7.1. Chapter Overview
7.2. Adare Pharma Solutions
7.2.1. Company Overview
7.2.2. Technology Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Colorcon
7.3.1. Company Overview
7.3.2. Technology Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Lupin
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Technology Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. Mayne Pharma
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Technology Portfolio
7.5.4. Recent Developments and Future Outlook
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions / Key Parameters
8.3. Methodology
8.4. Company Competitiveness Analysis: Taste Masking and Taste Assessment Service Providers Based in North America
8.5. Company Competitiveness Analysis: Taste Masking and Taste Assessment Service Providers Based in Europe
8.6. Company Competitiveness Analysis: Taste Masking and Taste Assessment Service Providers Based in Asia Pacific
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Taste Masking and Taste Assessment: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Partner
9.3.5. Analysis by Type of Partner and Year of Partnership
9.3.6. Analysis by Type of Service(s) Offered
9.3.7. Analysis by Scale of Operation
9.3.8. Analysis by Type of Formulation
9.3.9. Regional Analysis
9.3.10. Intercontinental and Intracontinental Agreements
9.3.11. Most Active Players based on Number of Partnerships
10. PATENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.2.1. Analysis by Type of Patent
10.2.2. Analysis by Patent Publication Year
10.2.3. Analysis by Type of Patent and Publication Year
10.2.4. Analysis by Type of Organization
10.2.5. Analysis by Geographical Distribution
10.2.6. Analysis by CPC Symbols
10.2.7. Leading Non-Academic Players based on Number of Patents
10.2.8. Leading Academic Players based on Number of Patents
10.3. Patent Benchmarking Analysis
10.2.7. Analysis by Patent Characteristics
10.4. Patent Valuation Analysis
10.5. Leading Patents based on Number of Citations
11. CASE STUDY: EXCIPIENTS USED IN PHARMACEUTICAL TASTE MASKING
11.1. Chapter Overview
11.2. Types of Pharmaceutical Excipients
11.3. Pharmaceutical Taste Masking Excipients: Overall Market Landscape
11.3.1. Analysis by Functional Properties
11.3.2. Analysis by Type of Formulation
11.4. Pharmaceutical Taste Masking Excipient Providers: Market Landscape
11.4.1. Analysis by Year of Establishment
11.4.2. Analysis by Company Size
11.4.2. Analysis by Location of Headquarters
11.4.2. Leading Players: Analysis by Number of Excipients
12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3 Global Pharmaceutical Taste Masking Market, 2022-2035
12.3.1. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Type of Formulation
12.3.1.1. Pharmaceutical Taste Masking Market for Solids, 2022-2035
12.3.1.2. Pharmaceutical Taste Masking Market for Solids, 2022-2035
12.3.2. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Type of Technique
12.3.2.1. Pharmaceutical Taste Masking Market for Coating Technique, 2022-2035
12.3.2.2. Pharmaceutical Taste Masking Market for Microencapsulation Technique, 2022-2035
12.3.2.3. Pharmaceutical Taste Masking Market for Organoleptic Method, 2022-2035
12.3.2.4. Pharmaceutical Taste Masking Market for Hot Melt Extrusion Technique, 2022-2035
12.3.2.5. Pharmaceutical Taste Masking Market for Inclusion Complexation Technique, 2022-2035
12.3.3. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Scale of Operation
12.3.3.1. Pharmaceutical Taste Masking Market for Preclinical / Clinical Scale, 2022-2035
12.3.3.2. Pharmaceutical Taste Masking Market for Commercial Scale, 2022-2035
12.3.4. Global Pharmaceutical Taste Masking Market, 2022-2035: Distribution by Key Geographical Regions
12.3.4.1. Pharmaceutical Taste Masking Market in North America, 2022-2035
12.3.4.2. Pharmaceutical Taste Masking Market in Europe, 2022-2035
12.3.4.3. Pharmaceutical Taste Masking Market in Asia Pacific and Rest of the World, 2022-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Glatt Pharmaceutical Services
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Phillipe Tschopp (Head of Business Development)
14.3 Senopsys
14.3.1. Company Snapshot
14.3.2. Interview Transcript: David Tisi (Director of Technical Operations)
14.4. Adare Pharma Solutions
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Brandon Keener (Business Development Associate)
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
